Exploration and Advancement of Drugs Within the Field of Bioinformatics: A Review

Pramod Chikkodi; Rushikesh Balu Shendage

doi:10.37591/(rrjobi).v10i3.1515

Abstract

After selection, research objectives fall under the supervision of either the pharmaceutical industry or pertinent academic institutions. The initial approach involves identifying drug molecules possessing the essential qualities necessary for the synthesis of targeted medications. Drug development constitutes the subsequent phase following the discovery of a drug and unfolds as a meticulous process aimed at introducing novel pharmaceuticals to the market. This intricate journey from discovery to market availability encompasses a substantial timeframe, often spanning two decades. Along this trajectory, the drug development process demands meticulous efforts, rigorous testing, and adherence to regulatory standards. The financial investment involved in this extensive undertaking can amount to a staggering $3 billion before the developed drug is deemed fit for clinical utilization. The pharmaceutical industry and academic institutions play a pivotal role in steering the course of research targets, overseeing the intricate process of drug development. The initial step involves discerning drug molecules endowed with the requisite properties, laying the foundation for subsequent phases. As drugs progress through the intricate stages of development, including pre-clinical and clinical trials, the cumulative investment of time and financial resources becomes evident. Ultimately, this exhaustive process aims to ensure that new drugs, backed by comprehensive research and testing, meet the stringent criteria for safety, efficacy, and regulatory approval before reaching the crucial stage of clinical utilization

Abstract

Keywords